Several individuals nationwide have filed Bard G2 IVC lawsuits against C.R. Bard over problems with the designs of inferior vena cava (IVC) filters. The plaintiffs accuse Bard of introducing defective design product in the market, which allegedly fractures and breaks inside the body, causing severe complications and injuries and death in some cases.
Recently, a widow has filed a product liability and personal injury lawsuit against C.R. Bard, alleging that the Bard G2 retrievable IVC filter failed after it was implanted in her husband’s vena cava. The lawsuit claims that the filter failed and tilted out of its position, puncturing the vein of the plaintiff’s husband and causing the blood clot to move to his heart or lungs. The failure of the device resulted in serious complications and ultimately death of the patient.
All Bard G2 IVC lawsuits share similar allegations, claiming that serious design problems with the filter make them susceptible to migrate to the lungs or heart or tilt out of position or even fracture, eventually failing to prevent heart or pulmonary blood clots. The migration of the metal pieces to the heart or lungs causes severe Bard G2 IVC side effects, resulting in serious injuries and even death.
What is Bard IVC Filter?
Made of metal, the device is designed to prevent blood clots from traveling from deep veins to lungs for people at a risk of suffering pulmonary embolism. Like the first generation G2 filter, the second generation G2 filter is plagued with migration, fracturing, and perforation. The first-generation filter had a very high failure rate, and the speed with which defective device reports are surfacing, it is unlikely that the repackaged Bard G2 IVC filter is any better than its previous version.
Bard G2 IVC lawsuits allege that Bard was aware of the defective IVC filter design, but chose to ignore reports of filter fractures and migration inside the body and continued to market the dangerous devices.
Serious concerns are raised at the potential risk of the spider-like IVC filters. An IVC filter study finds that patients who receive an IVC filter are potentially at a double risk of pulmonary embolism compared to those who take blood thinners alone.
Side Effects
- Improper placement of the device leads to chronic pelvic pain, migration
- Puncture or breaking of the device
- The device may even ‘disappear’ in some cases, becoming undetectable in the body
- Severe migraine
- Puncture of the uterus
- Tear of the colon
- Severe allergic reactions to the device or any of its metal components
Studies Link Device to Complications
Another study published in the July 2015 issue of JAMA warned of long-term risks of IVC filters, claiming that the risks outnumber the benefits. The failure of Bard in placing warning labels on the device for users to get the temporary device removed within one to two months of implantation has resulted in severe injuries for patients who failed to get the filter removed despite passage of the ideal device removal time. As a result, thousands of people have been severely injured after suffering Bard G2 IVC side effects. Shockingly the injuries were avoidable had the defendant informed users and doctors regarding the timely and diligent removal of the devices.
In May 2014, the FDA urged doctors to remove the temporary filters within 29-54 days of device implantation after there was no longer a risk of pulmonary embolism. The Federal Drug Administration accepted that the medicine fraternity was not adequately warned about the importance of device retrieval.
If you or a loved one has suffered from C.R. Bard G2 IVC side effects, you have a potential claim against C.R. Bard and can seek compensatory damages for the pain, suffering, and trauma. Get in touch with our experienced Bard G2 IVC attorneys to investigate your case and help you get justice. Please call us today at (800) 632-1404 for a free case evaluation.